Vasoactive effects of growth factors.
Berk
B C
BC
Department of Medicine, Emory University, Atlanta, GA 30322.
Alexander
R W
RW
D000804:Angiotensin II / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D004815:Epidermal Growth Factor / Q000494:pharmacology; D006133:Growth Substances / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D007375:Interleukin-1 / Q000502:physiology; D009119:Muscle Contraction; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D011493:Protein Kinase C / Q000502:physiology; D014661:Vasoconstriction / Q000187:drug effects*; D014664:Vasodilation / Q000187:drug effects
D006133:Growth Substances; D007375:Interleukin-1; D010982:Platelet-Derived Growth Factor; D000804:Angiotensin II; D004815:Epidermal Growth Factor; D011493:Protein Kinase C; D002118:Calcium